Cycle Monitoring

with OvuSense

Introducing

The most advanced cycle monitoring system in the world.

Powered by OvuSense - a clinically proven fertility monitor with patented Core Body Temperature technology - Nabta Cycle Monitoring is designed to give you an accurate picture of your cycle and optimise your chances of falling pregnant.

Stats about ovusense

Up to 99%

Clinically proven accuracy in the prediction and detection of ovulation.

150,000+

Menstrual cycles tracked in women trying to conceive.

92%

Would recommend OvuSense to a friend (and many do!).

AS FEATURED IN

What makes us different?

Advanced cycle predictions, backed by science.

Clinically Proven

OvuSense was developed by specialists and is backed by over 157,000 cycles of use, 2 clinical trials and 6 peer-reviewed publications, confirming the medical basis for core body temperature monitoring.

8 Day Fertile Window

In addition to accurate ovulation predictions, OvuSense provides a 99% accurate, full eight-day fertile window at the start of each cycle – helping you take back control of planning for pregnancy.

Live Predictions

Unlike any other monitor, OvuSense can alert you up to 24-hours before you ovulate based on your in-cycle data. Accurate 96% of the time, this gives you more time to try to get pregnant each cycle.

Certified, Safe and Effective

OvuSense is the only fertility monitor on the market with full regulatory approval in the USA (510k), Europe (CE), Canada, Australia and the UAE. Why trust your cycle to anyone else when you can use OvuSense?

OvuSense is a vaginal sensor. Simple to use, it fits comfortably like a tampon, with easy to understand cycle insights and ovulation predictions, visible in real time through the Nabta app.

OVUSENSE IS A REGISTERED TRADEMARK OF FERTILITY FOCUS LTD, UK.

Praise for OvuSense

Loved by thousands of women around the world.

How does it work?

Nabta Cycle Monitoring with OvuSense

STEP 1

Download the Nabta نبتة app.

Register an account using the same email address you used when you purchased OvuSense.

STEP 2

Set your health goal.

Aya will ask you what your main goal is with Nabta. Confirm that you are trying to get pregnant. Aya will ask you a few more questions about your cycle and then take you to the trying to conceive mode of the app.

STEP 3

Sync your OvuSense and start tracking!

You should see the OvuSense section on the Home page with a request to sync your sensor. Follow the step-by-step guide included in your starter pack. Happy OvuSense'ing!

Is OvuSense For Me?

Irregular cycles? PCOS? The answer is YES.

Choose your Starter Pack

Save up to 20% on annual plans. Change plans anytime, conditions apply, see FAQs.

Premium

Starter Pack
AED 499
00
  • 2 Month Premium Membership
  • 10 Minute Fertility Consultation
  • 1x Vaginal Sensor
  • 1x Sensor Case
  • Get Started Guide

PREMIUM+

25% Membership Discount
AED 749
00
  • 12 Month Premium Membership
  • 2x 10 Minute Fertility Consultations
  • 1x Vaginal Sensor
  • 1x Sensor Case
  • Get Started Guide
Popular

EXCLUSIVE

40% Membership Discount
AED 1,249
00
  • 12 Month Exclusive Membership
  • Monthly Fertility Consultations
  • 1x Vaginal Sensor
  • 1x Sensor Case
  • Get Started Guide

OvuSense FAQs

OvuSense is different to anything else you may have heard of, or used previously to monitor your fertility. That’s because it measures core body temperature using a specially designed vaginal sensor proven in over 157,000 cycles of use. The vaginal sensor is used overnight only, and data is downloaded to the Nabta نبتة app each morning. Nabta Cycle Monitoring with OvuSense provides live updates, predicting ovulation up to 24 hours in advance using your current cycle data, then confirming the date of ovulation, all in one device.

By providing core temperature data in real time, throughout each cycle, OvuSense solves the issues that variable ovulation causes when it comes to monitoring your fertility. Even if you have completely regular ovulation, the live prediction with a positive predictive value of 96% [a] and the 99% accurate ovulation confirmation [b] improve your chances of successful conception.

OvuSense effectively combines the benefits of OPKs with the benefits of BBT measurement, and all with the convenience of monitoring in a single device. However, OvuSense is more accurate than both OPKs and BBT measurement, and goes one step further by enabling clinical monitoring in conjunction with the tests offered by your doctor.

OvuSense has been clinically proven in 5 key peer reviewed publications [c], [1], [2] which reported on 2 clinical trials. The OvuSense technology also has 8 granted patents [3]

OvuSense provides more accurate results by using a vaginal sensor. Some may find this less convenient than tracking using an external device, but many users report that the routine of using OvuSense takes the hassle and guesswork out of understanding their cycles. The comfort and ease of use of the sensor was also published clinically [4].
OvuSense is an FDA-approved, CE-certified medical device. [a] The positive predictive value measures how many of the predicted ovulations OvuSense gets right. [b] The accuracy measures how many positive and absent ovulations OvuSense confirms correctly. [c] Note: 4 of the OvuSense publications were clinical posters shown at the annual meetings of the two largest clinical societies for reproductive medicine: ESHRE and ASRM. Poster publications are reviewed by a committee of peers for both societies and only allowed to be presented if deemed of sufficient scientific merit and robustness. They are then published as part of the proceedings of the meetings in the official society journals ‘Human Reproduction’ and ‘Fertility and Sterility’, respectively. As is the norm with the development of medical devices, the OvuSense trials were sponsored by the company but the primary authors of the posters are independent clinicians. [1] The key publication outlining prediction of ovulation was shown at the 2014 ESHRE meeting: Papaioannou S, Delkos D, Pardey J (2014). [2] The claims for accuracy are based on the data set shown in [1], originally published at the 2013 ASRM meeting as a quality index: Papaioannou S, Aslam M (2013). [3] US Patents: US8684944US8496597US9155522US9155523US20190110692; European patents: EP1485690EP2061380; Chinese patent: CN1650154. [4] The comfort and ease of use of OvuSense were published in the Journal of Obstetrics and Gynecology in 2013, and this survey is repeated annually with our customers with continuous as good or better results: Papaioannou S, Aslam M (2013).

Want to learn more about Cycle Monitoring with OvuSense? Contact us directly on 800 NABTA or via any of our social media channels. Search @NabtaHealth.